LGALS3 and paracoccidioidomycosis: Since increased Gal-3 expression was previously described during human and experimental inflammatory diseases (25, 26), and recently in C. neoformans infection (15), we measured Gal-3 levels in serum samples from individuals suffering from PCM, either the acute or chronic PCM form.